Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer (of any type, including triple-negative, hormone receptor-positive/HER2-negative, or HER2-positive) or prostate cancer that has spread to multiple sites in the body, and where a new round of treatment is being considered.
- People who have not yet started a new specific treatment for their breast or prostate cancer at the time of joining the trial.
- People aged 18 or older who are reasonably able to carry out daily activities (confirmed with trial site regarding the specific activity scale used).
- People who are covered by the French Social Security scheme.
- People who have read and signed an informed consent form before joining the trial and before any trial-related procedures take place.
Who may not be able to join:
- People who have another health condition that could interfere with the trial procedures running as planned.
- People whose psychological, family, geographic, or personal circumstances may make it difficult to follow the trial's schedule and requirements.
- People who are currently in prison or under a form of legal guardianship or protection.
- People who have had another solid tumour (other than certain non-invasive cancers of the breast or cervix) within the past 5 years.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 05 31 15 51 22
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The rate of patients with at least one additional CTC detected by the SmartCatch® method compared with the standard approach (CellSearch®).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.